Research output per year
Research output per year
- 20 results
Search results
-
2025
A Difficult Conversation
Geynisman, D. M., Apr 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 4, e250019.Research output: Contribution to journal › Editorial
-
A New Administration and JNCCN
Geynisman, D. M., Mar 2025, In: Journal of the National Comprehensive Cancer Network. 23, 3, p. 65-65 1 p.Research output: Contribution to journal › Editorial
-
Changes for JNCCN in 2025
Geynisman, D. M., Jan 2025, In: Journal of the National Comprehensive Cancer Network : JNCCN. 23, 1, e250003.Research output: Contribution to journal › Editorial
-
2024
Artificial Intelligence and Oncology
Geynisman, D. M., Jul 1 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 5, p. 277 1 p.Research output: Contribution to journal › Editorial
-
Cancer Health Disparities
Geynisman, D. M., Aug 1 2024, In: Journal of the National Comprehensive Cancer Network : JNCCN. 22, 6, p. 363-364 2 p.Research output: Contribution to journal › Editorial
-
Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analyses
Zarrabi, K. K., Miron, B. & Geynisman, D. M., Mar 31 2024, In: Translational Andrology and Urology. 13, 3, p. 405-466 62 p.Research output: Contribution to journal › Editorial
Open Access -
Hello JNCCN Readers
Geynisman, D., Jun 2024, In: Journal of the National Comprehensive Cancer Network. 22, 2D, 1 p., e240031.Research output: Contribution to journal › Editorial
Open Access -
Introducing the New Editor-in-Chief
Tempero, M. & Geynisman, D. M., May 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 4, p. 205 1 p.Research output: Contribution to journal › Editorial
-
The Oncologist Outside the Exam Room
Geynisman, D. M., Dec 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 10, p. 645-646 2 p.Research output: Contribution to journal › Editorial
-
Welcome New Fellows!
Geynisman, D. M., Oct 2024, In: Journal of the National Comprehensive Cancer Network : JNCCN. 22, 8, p. 511 1 p.Research output: Contribution to journal › Editorial
-
2022
Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma
Miron, B. & Geynisman, D. M., Oct 2022, In: European Urology. 82, 4, p. 374-376 3 p.Research output: Contribution to journal › Editorial
6 Scopus citations -
2021
Systemic Therapy for Advanced Non–clear-Cell Renal Cell Carcinoma: Slow but Definite Progress
Geynisman, D. M. & Plimack, E. R., Aug 2021, In: European Urology. 80, 2, p. 171-173 3 p.Research output: Contribution to journal › Editorial
7 Scopus citations -
2019
The volume-outcome relationship in kidney cancer: is more really better?
Kadow, B., Joshi, S., Kutikov, A., Handorf, E., Smaldone, M., Uzzo, R. & Geynisman, D., Dec 2019, In: Annals of Translational Medicine. 7, Suppl 8, p. S336 3 p., S336.Research output: Contribution to journal › Editorial
-
2018
Chemoimmunotherapy in Metastatic Urothelial Carcinoma
Geynisman, D. M., Abbosh, P. H., Plimack, E. R. & Zibelman, M., May 2018, In: European Urology. 73, 5, p. 760-762 3 p.Research output: Contribution to journal › Editorial
-
What can the National Cancer Database tell us about disparities in advanced bladder cancer outcomes?
Joshi, S. S., Handorf, E. R., Smaldone, M. C. & Geynisman, D. M., May 1 2018, In: Translational Andrology and Urology. 7, 4, p. 732-735 4 p.Research output: Contribution to journal › Editorial
Open Access5 Scopus citations -
2017
Patient-reported and Cost-effectiveness Outcomes Are Key to Determining the Optimal Therapeutic Sequence for Patients with Metastatic Renal Cell Carcinoma
Ristau, B. T. & Geynisman, D. M., Feb 1 2017, In: European Urology. 71, 2, p. 210-212 3 p.Research output: Contribution to journal › Editorial
1 Scopus citations -
2016
Second-generation Androgen Receptor–targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early?
Geynisman, D. M., Plimack, E. R. & Zibelman, M., Dec 1 2016, In: European Urology. 70, 6, p. 971-973 3 p.Research output: Contribution to journal › Editorial
7 Scopus citations -
2015
Corticosteroids and prostate cancer: Friend or foe?
Geynisman, D. M., Szmulewitz, R. Z. & Plimack, E. R., May 1 2015, In: European Urology. 67, 5, p. 874-875 2 p.Research output: Contribution to journal › Editorial
5 Scopus citations -
Osteoclast inhibitors in advanced prostate cancer: Does the benefit extend beyond skeletal-related events?
Geynisman, D. M., Ross, E. A. & Plimack, E. R., Oct 1 2015, In: European Urology. 68, 4, p. 578-580 3 p.Research output: Contribution to journal › Editorial
-
2012
A trial postmortem: Challenges in conducting a randomized, double-blind, phase 2 study in men with castration-resistant prostate cancer
Geynisman, D. M., Szmulewitz, R. Z. & Stadler, W. M., Nov 2012, In: European Urology. 62, 5, p. 864-866 3 p.Research output: Contribution to journal › Editorial